Cargando…

The long-term effects of insulin use in incident cystic fibrosis-related diabetes: a target trial emulated using longitudinal national registry data

INTRODUCTION: Cystic fibrosis-related diabetes (CFRD) is a common complication of cystic fibrosis and is associated with deleterious clinical outcomes. Insulin is recommended as a treatment by international guidelines. However, there are scarce clinical trial data to support the use of insulin, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Granger, Emily, Keogh, Ruth H., Frost, Freddy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638829/ https://www.ncbi.nlm.nih.gov/pubmed/36382232 http://dx.doi.org/10.1183/23120541.00170-2022

Ejemplares similares

Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data
por: Granger, Emily, et al.
Publicado: (2023)

Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor?
por: Granger, Emily, et al.
Publicado: (2022)

Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data()
por: Keogh, Ruth H., et al.
Publicado: (2018)

Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data
por: Schlüter, Daniela K, et al.
Publicado: (2022)

Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study
por: Tanner, Kamaryn T., et al.
Publicado: (2022)

A guide to interpreting estimated median age of survival in cystic fibrosis patient registry reports
por: Keogh, Ruth H., et al.
Publicado: (2018)

Dynamic Prediction of Survival in Cystic Fibrosis: A Landmarking Analysis Using UK Patient Registry Data
por: Keogh, Ruth H., et al.
Publicado: (2019)

Data Resource Profile: The UK Cystic Fibrosis Registry
por: Taylor-Robinson, David, et al.
Publicado: (2018)

Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
por: Yong, Jun, et al.
Publicado: (2018)

Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials
por: Keogh, Ruth H, et al.
Publicado: (2022)

Gene therapy-emulating small molecule treatments in cystic fibrosis airway epithelial cells and patients
por: Yang, Q., et al.
Publicado: (2019)

Case Report: First report of Elizabethkingia miricola infection in a patient with cystic fibrosis
por: Frost, Freddy, et al.
Publicado: (2018)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Results from an online survey of adults with cystic fibrosis: Accessing and using life expectancy information
por: Keogh, Ruth H., et al.
Publicado: (2019)

Cystic Fibrosis Mortality in Childhood. Data from European Cystic Fibrosis Society Patient Registry
por: Zolin, Anna, et al.
Publicado: (2018)

51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry
por: Cheng, S., et al.
Publicado: (2022)

emulator
Publicado: (1999)

Emulation
por: Powell, T. S.
Publicado: (1878)

Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach
por: Frost, Freddy, et al.
Publicado: (2019)

The changing demography of the cystic fibrosis population: forecasting future numbers of adults in the UK
por: Keogh, Ruth H., et al.
Publicado: (2020)

Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry
por: Gardner, Aaron I, et al.
Publicado: (2019)

Erratum to: Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry
Publicado: (2021)

Emulators terminal
Publicado: (2016)

Creating longitudinal datasets and cleaning existing data identifiers in a cystic fibrosis registry using a novel Bayesian probabilistic approach from astronomy
por: Hurley, Peter Donald, et al.
Publicado: (2018)

Using Negative Control Outcomes and Difference-in-Differences Analysis to Estimate Treatment Effects in an Entirely Treated Cohort: The Effect of Ivacaftor in Cystic Fibrosis
por: Newsome, Simon J, et al.
Publicado: (2021)

The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry
por: Ryerson, Christopher J., et al.
Publicado: (2016)

Developing an ecological approach to physical activity promotion in adults with Cystic fibrosis
por: Shelley, James, et al.
Publicado: (2022)

Evaluation of a five-year predicted survival model for cystic fibrosis in later time periods
por: Liou, Theodore G., et al.
Publicado: (2020)

44: Characterizing the COVID-19 pandemic among Canadians living with cystic fibrosis: A Canadian Cystic Fibrosis Registry study
por: Cheng, S., et al.
Publicado: (2021)

The Diagnosis of Cystic Fibrosis in Adult Age. Data from the Italian Registry
por: Padoan, Rita, et al.
Publicado: (2021)

Sustained Reduction in Time to Data Entry in the Cystic Fibrosis Foundation Registry
por: Nay, Laura, et al.
Publicado: (2022)

Longitudinal development of the airway microbiota in infants with cystic fibrosis
por: Ahmed, Bushra, et al.
Publicado: (2019)

Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis
por: Whelan, Fiona J., et al.
Publicado: (2017)

Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progression
por: Szczesniak, Rhonda D., et al.
Publicado: (2019)

First and second wave of SARS-CoV2 in Italian Cystic Fibrosis patients: Data from Italian Cystic Fibrosis Registry
por: Padoan, Rita, et al.
Publicado: (2021)

Methods of analysis for survival outcomes with time-updated mediators, with application to longitudinal disease registry data
por: Tanner, Kamaryn T, et al.
Publicado: (2022)

Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis
por: Ramsey, Mitchell L, et al.
Publicado: (2022)

The 3081/e Emulator
por: DELPHI Collaboration
Publicado: (1982)

IBM 360 Emulators
por: DELPHI Collaboration
Publicado: (1982)

DDM Workload Emulation
por: Vigne, R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_plej898gdbh7gsdv6v19i713jq